Andrew ElBardissi MD Overview
- Firm
- Deerfield Manage...
- Primary Position
-
Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
18
- Med. Deal Size
-
- Med. Valuation
-
Andrew ElBardissi MD General Information
Biography
Dr. Andrew ElBardissi serves as a Partner at Deerfield Management. He serves as a Board Member at Bitterroot, Adela Bio, Endologix LLC. & GeneDx Holding. He serves as Board Member at Aurion Biotech. He serves as Board Member at Medical Microinstruments. He serves as Board Member at Element Science. Previously, he served as a Board Member at Farapulse. He served as a Board Member at Singular Genomics. Previously, he served as Principal at Longitude Capital. He serves as a Board Member at Acutus Medical, Axon Therapies, CathWorks, Conventus Orthopaedics, Epic Sciences, InCarda Therapeutics, NeoChord, Sema4, SentreHEART, Singular Genomics, Sollis Therapeutics, Encodia, and V-Wave. He also served as Board Member at MTrap. He served as Board Member at RenalGuard & Reprieve Cardiovascular. He serves as Board Member at Bitterroot Bio. He serves as Board Member at Conventus Flower Orthopedics.
Contact Information
Address
- 345 Park Avenue South
- New York, NY 10010
- United States
Andrew ElBardissi MD Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Deerfield Management | Investor | Partner | New York, NY | Venture Capital |
Andrew ElBardissi MD Board Seats (18)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Acutus Medical | Diagnostic Equipment | Publicly Held | Formerly VC-backed | Carlsbad, CA | |
| Adela | Diagnostic Equipment | Privately Held (backing) | Venture Capital-Backed | Foster City, CA | |
| Aurion Biotech | Biotechnology | In IPO Registration | Venture Capital-Backed | Seattle, WA | |
| Axon Therapies | Surgical Devices | Privately Held (backing) | Venture Capital-Backed | Santa Clara, CA | |
| Bitterroot | Restaurants and Bars | Privately Held (backing) | Private Debt Financed | Seattle, WA |
Andrew ElBardissi MD Lead Partner on Deals (27)
Andrew ElBardissi MD has been the lead partner on 27 deals. Their latest deal was with Singular Genomics, a drug discovery company. The deal was made on 19-Feb-2025.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Singular Genomics | 19-Feb-2025 | Buyout/LBO | Completed | Drug Discovery | San Diego, CA | |
| Pleno | 12-Dec-2024 | Completed | Discovery Tools (Healthcare) | San Diego, CA | ||
| Adela | 27-Jul-2024 | Completed | Diagnostic Equipment | Foster City, CA | ||
| Bitterroot Bio | 07-Jun-2023 | Completed | Drug Discovery | Palo Alto, CA | ||
| Epic Sciences | 27-Feb-2023 | Completed | Diagnostic Equipment | San Diego, CA | ||
| Medical Microinstruments | 20-Jul-2022 | Completed | Surgical Devices | Jacksonville, FL | ||
| Pleno | 25-May-2022 | Completed | Discovery Tools (Healthcare) | San Diego, CA | ||
| Epic Sciences | 29-Apr-2022 | Completed | Diagnostic Equipment | San Diego, CA | ||
| Aurion Biotech | 12-Apr-2022 | Later Stage VC (Series C) | Completed | Biotechnology | Seattle, WA | |
| GeneDx Holding | 22-Jul-2021 | PIPE | Completed | Other Healthcare Technology Systems | Stamford, CT |
Andrew ElBardissi MD Network (467)
Board Members (213)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Carlo Marcoaldi | Medical Microinstruments | Self | Jacksonville, FL | |
| Paul Brown Ph.D | Adela | Self | Foster City, CA | |
| DA32 Life Science Tech Acquisition | Self | New York, NY | ||
| Conventus Flower Orthopedics | Bluestem Capital Company | Horsham, PA | ||
| RenalGuard | RenalGuard | Milford, MA |
Portfolio Executives (235)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| David Daly | Singular Genomics | Chief Operating Officer & President | 19-Feb-2025 | San Diego, CA |
| Jyotsna Ghai Ph.D | Singular Genomics | Chief Operating Officer, Operations | 19-Feb-2025 | San Diego, CA |
| Singular Genomics | Chief Business Officer | 19-Feb-2025 | San Diego, CA | |
| Singular Genomics | Chief Financial Officer | 19-Feb-2025 | San Diego, CA | |
| Singular Genomics | Co-Founder & CSO | 19-Feb-2025 | San Diego, CA |
Fund Team Members (19)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Leslie Henshaw | Deerfield Management | Deerfield Healthcare Innovations Fund | New York, NY |
| Leslie Henshaw | Deerfield Management | Deerfield Healthcare Innovations Fund II | New York, NY |
| Deerfield Management | New York, NY | ||
| Deerfield Management | New York, NY | ||
| Deerfield Management | New York, NY |
Andrew ElBardissi MD Affiliated Funds (3)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Deerfield Private Design Fund IV | Deerfield Management | Diversified Private Equity | Closed | 2016 | ||||
| Deerfield Healthcare Innovations Fund | Deerfield Management | Venture Capital - Early Stage | Closed | 2015 | ||||
| Deerfield Healthcare Innovations Fund II | Deerfield Management | Venture Capital - Early Stage | Closed | 2019 |
Andrew ElBardissi MD FAQs
-
Who is Andrew ElBardissi MD?
Dr. Andrew ElBardissi serves as a Partner at Deerfield Management.
-
How much does Andrew ElBardissi MD typically invest?
Andrew ElBardissi MD's median deal size is .
-
What is Andrew ElBardissi MD’s main position?
Andrew ElBardissi MD’s primary position is Partner.
-
What are the contact details for Andrew ElBardissi MD?
Andrew ElBardissi MD’s email address is ae and his phone number is +1 (650) .
-
How many active board seats does Andrew ElBardissi MD hold?
Andrew ElBardissi MD holds 18 board seats including Acutus Medical, Adela, Aurion Biotech, Axon Therapies, and Bitterroot.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
